U.S., Aug. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07099430) titled 'A Trial of LBL-024 Monotherapy, LBL-024 Combined With LBL-007 or Toripalimab in Patients With Advanced Melanoma.' on July 25.
Brief Summary: This study is an open-label, multicenter phase Ib/II study to evaluate the efficacy and safety of LBL-024 monotherapy, LBL-024 in combination with LBL-007 or toripalimab in patients with advanced melanoma,To evaluate the preliminary efficacy and safety of LBL-024 monotherapy and combination therapy in patients with advanced melanoma.
Study Start Date: Aug. 30
Study Type: INTERVENTIONAL
Condition:
Advanced Melanoma
Intervention:
DRUG: LBL-024 for Injection
LBL-024 , Intravenous infusion.
...